Design and Screening of New Lead Compounds for Autism Based on QSAR Model and Molecular Docking Studies

Molecules. 2022 Oct 26;27(21):7285. doi: 10.3390/molecules27217285.

Abstract

The purpose of the present study aims to develop a satisfactory model for predicting pro-social and pro-cognitive effects on azinesulfonamides of cyclic amine derivatives as potential antipsychotics. The three dimensional-quantitative structure affinity relationship (3D-QSAR) study was performed on a series of azinesulfonamides of cyclic amine derivative using comparative molecular similarity indices analysis (CoMSIA). The best statistical model of CoMSIA q2, r2, SEE and F values are 0.664, 0.973, 0.087, and 82.344, respectively. Based on the model contour maps and the highest activity structure of the 43rd compound, serial new structures were designed and the 43k1 compound was selected as the best structure. The dock results showed a good binding of 43k1 with the protein (PDB ID: 6A93). The QSAR model analysis of the contour maps can help us to provide guidelines for finding novel potential antipsychotics.

Keywords: antipsychotics; autism; azinesulfonamides; cyclic amine derivatives.

MeSH terms

  • Amines
  • Antipsychotic Agents* / pharmacology
  • Autistic Disorder*
  • Humans
  • Lead
  • Molecular Docking Simulation
  • Quantitative Structure-Activity Relationship

Substances

  • Lead
  • Antipsychotic Agents
  • Amines

Grants and funding

This research received no external funding.